Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer
about
A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma CareCYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET)Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and preventionTargeted therapy for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus.Ritonavir and ixazomib kill bladder cancer cells by causing ubiquitinated protein accumulation.Recent advances in drug repositioning for the discovery of new anticancer drugsRitonavir acts synergistically with panobinostat to enhance histone acetylation and inhibit renal cancer growth.Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir.CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series.The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin.Breast Cancer in the Setting of HIVEffects of HIV protease inhibitors on progression of monocrotaline- and hypoxia-induced pulmonary hypertension in rats.The human immunodeficiency virus protease inhibitor ritonavir is potentially active against urological malignancies.Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists' arsenal.Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analysesDevelopment of a Tumour Growth Inhibition Model to Elucidate the Effects of Ritonavir on Intratumoural Metabolism and Anti-tumour Effect of Docetaxel in a Mouse Model for Hereditary Breast Cancer.Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line.Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metforminRepositioning HIV protease inhibitors as cancer therapeuticsRitonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells.The impact of nelfinavir exposure on cancer development among a large cohort of HIV-infected patientsCombining metformin and nelfinavir exhibits synergistic effects against the growth of human cervical cancer cells and xenograft in nude mice.Targeting endoplasmic reticulum signaling pathways in cancer.HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives?Identifying the optimal dose of ritonavir in the treatment of malignancies.Tubocapsenolide A, a novel withanolide, inhibits proliferation and induces apoptosis in MDA-MB-231 cells by thiol oxidation of heat shock proteins.Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model.Ritonavir inhibits HIF-1α-mediated VEGF expression in retinal pigment epithelial cells in vitro.Ritonavir-Mediated Induction of Apoptosis in Pancreatic Cancer Occurs via the RB/E2F-1 and AKT Pathways.Lopinavir inhibits meningioma cell proliferation by Akt independent mechanism.Breast enlargement in an HIV-infected man on combined antiretroviral therapy: what if it was carcinoma?Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria.Counteracting Akt Activation by HIV Protease Inhibitors in Monocytes/Macrophages.p53 and metabolism: from mechanism to therapeutics.
P2860
Q26851160-7D9686F4-1172-4B01-B02D-84798983B6DDQ28307304-1594C5E9-CCAC-4EA7-BB78-CA895F276A6DQ33642284-F859FD0A-486C-4401-902B-92619A4150D2Q33793543-BBEC45C1-6A21-4F80-8767-97F08A1ECB68Q33823282-F97DD6ED-9CEA-467F-8CCA-D23FC6C6EF16Q33845068-E1B24A2C-1BE2-40F8-AB9F-426BF855C393Q34265747-E03DFDEE-D496-4508-A58F-461EC8A999BAQ34435827-AE4A4BCB-F9D5-4561-B790-768316C96491Q34437996-4683D912-EA6E-4995-AA2D-3657C7DC2E2EQ34722581-5A8D6437-D44C-4F98-9C57-A0083F0B412BQ35013477-12DBA44C-2FC4-4EAE-9A1A-9B48D2E62BA0Q35026128-54D7482E-9C77-4553-AC37-7CE31CF93CB0Q35151656-B7F42AD3-0666-44E6-96D0-3A1E7764BB06Q35444159-81944911-D6D3-4F54-9542-363CDF6E05A0Q35653603-BDE0B413-C0D8-4035-84D8-60502DE69DA0Q36303278-E21C48E9-6365-44EA-B647-41880498106FQ36653951-EAC97108-9E79-4F41-B60F-C77E841A978EQ36796376-D82B3C0A-0030-4C78-B4CD-EDD7B319B898Q36905125-698F31D9-737F-42B4-8D01-FFB388E3E2F1Q37192579-12C3842E-6246-46F0-874F-C31334A3776DQ37215121-57EE81CF-9A5B-4BCB-8742-2DBAB4813015Q37287616-3EE22895-263C-4EE7-ACA7-361039C84C6CQ37676300-5977A4B5-06A6-4780-A6A2-330192879A1BQ38017716-651A2ACE-2255-4A77-83E5-542FA2187109Q39015233-AEA6426D-3C6F-4265-ACDE-4CF42C23D941Q39061564-14CFD591-71E6-430E-8BCE-CED483781581Q39987469-1694E4EF-4E0D-4ADB-8D54-F3C849FD6582Q40617502-80350296-8F40-4AE4-B0E1-548BE7AFD656Q41869840-8205F9E0-9613-4544-BD20-ABEFAF6FEB59Q41918598-94DA8989-9983-47C6-A607-48948473A14FQ42473677-A23A3FB4-B630-41EF-97BF-862A9E5674EFQ43055396-9159B488-AB25-424D-9CCA-EEBF38BBEA14Q46065405-02621878-1C58-4A17-8444-61247CBECC37Q54236415-F75C374A-A594-4E5F-9536-996781B09915Q55002919-6A967FFD-380E-4A32-A876-705406780EA5
P2860
Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effects of HIV protease inhibi ...... proliferation in breast cancer
@en
Effects of HIV protease inhibi ...... roliferation in breast cancer.
@nl
type
label
Effects of HIV protease inhibi ...... proliferation in breast cancer
@en
Effects of HIV protease inhibi ...... roliferation in breast cancer.
@nl
prefLabel
Effects of HIV protease inhibi ...... proliferation in breast cancer
@en
Effects of HIV protease inhibi ...... roliferation in breast cancer.
@nl
P2093
P2860
P1476
Effects of HIV protease inhibi ...... proliferation in breast cancer
@en
P2093
Anjaiah Srirangam
Christie M Orschell
David A Potter
David Donner
Edward F Srour
George W Sledge
Hiromitsu Kishimoto
J Christopher Gorski
John Hawes
Justin Hamilton
P2860
P304
P356
10.1158/1078-0432.CCR-05-1167
P407
P577
2006-03-01T00:00:00Z